Hot Pursuit     19-Mar-25
Aurobindo Pharma jumps as Telangana unit gets VAI status from USFDA
Aurobindo Pharma rose 1.82% to Rs 1,157.90 after its subsidiary, Apitoria Pharma, received an establishment inspection report (EIR) from the U.S. Food and Drug Administration for its active pharmaceutical ingredient (API) facility in Telangana.

The USFDA conducted an inspection of the facility from 9 December 2024 to 17 December 2024 and classified the inspection status as Voluntary Action Indicated (VAI).

Aurobindo Pharma is principally engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals, and related services.

Aurobindo Pharma reported a 10.04% decline in consolidated net profit to Rs 845.57 crore in Q3 FY25, compared to Rs 939.97 crore posted in Q3 FY24. Revenue from operations increased 8.53% year on year (YoY) to Rs 7,978.52 crore in the quarter ended 31 December 2024.

Previous News
  Aurobindo Pharma update on acquisition of balance stake in Purple Bellflower, South Africa
 ( Corporate News - 02-May-24   14:58 )
  USFDA inspects Aurobindo Pharma USA Inc.'s warehouse facility in New Jersey
 ( Corporate News - 20-Feb-25   09:02 )
  Volumes spurt at Aurobindo Pharma Ltd counter
 ( Hot Pursuit - 03-Apr-25   11:00 )
  Auro Pharma Q4 PAT jumps 80% YoY to Rs 909 crore
 ( Hot Pursuit - 27-May-24   12:34 )
  Aurobindo Pharma Ltd drops for fifth straight session
 ( Hot Pursuit - 13-Dec-24   13:35 )
  Aurobindo Pharma Ltd spurts 1.18%, rises for third straight session
 ( Hot Pursuit - 29-Jul-24   13:05 )
  Aurobindo Pharma to table results
 ( Corporate News - 30-Oct-23   12:54 )
  Aurobindo Pharma arm gets USFDA nod for anesthetic drug
 ( Hot Pursuit - 11-Sep-24   12:26 )
  Auro Pharma slides as Q4 PAT dips 12% YoY to Rs 560 cr
 ( Hot Pursuit - 29-May-23   09:52 )
  Aurobindo Pharma Ltd rises for third straight session
 ( Hot Pursuit - 20-Jan-25   13:06 )
  Auro Pharma’s Andhra Pradesh facility gets 3 USFDA observations
 ( Hot Pursuit - 08-Apr-24   10:48 )
Other Stories
  Tata Communications gains after concluding issue of CPs amounting to Rs 500 crore
  22-Apr-25   11:20
  Tata Investment slides as Q4 PAT tumbles 38% to Rs 38 crore; declares dividend of Rs 27/sh
  22-Apr-25   11:17
  Rajratan Global Wire hits the roof after Q4 PAT gains 63% QoQ to Rs 15.20 cr
  22-Apr-25   11:17
  Aditya Birla Money hits the floor after Q4 PAT slumps 43% YoY to Rs 9 cr
  22-Apr-25   11:07
  Banks rise as RBI eases liquidity norms
  22-Apr-25   11:05
  Volumes jump at Kajaria Ceramics Ltd counter
  22-Apr-25   11:00
  Pitti Engineering rises after Q4 PAT gains 26% QoQ to Rs 36.14 cr
  22-Apr-25   10:35
  Lotus Chocolate hits the floor after Q4 PAT slumps 65% YoY
  22-Apr-25   10:32
  Alok Inds rallies as Q4 net loss narrows to Rs 74 crore
  22-Apr-25   10:22
  Anant Raj edges higher after Q4 PAT rises over 51% YoY
  22-Apr-25   10:13
Back Top